Model-Informed Drug Discovery and Development webinars

Drug discovery and development webinars are your opportunity to see how quantitative modeling influences drug development decisions and learn from teams who apply these approaches in their daily work:

Theory sessions led by our senior scientists, covering state‑of‑the‑art MID3 methodologies (QSP, systems biology, population PK/PD, joint longitudinal–TTE modeling, MBMA, AI/ML) and how we ensure excellence, quality, compliance, and credibility in every project.

Hands‑on case webinars built around real projects in oncology, autoimmunity, infectious and respiratory diseases, cardiovascular and metabolic indications – showing how modeling results shaped regulatory strategy, RP2D justification, study design, and life‑cycle decisions.

End‑to‑end MID3 stories demonstrating how automated, fully reproducible workflows – from data processing to reporting and peer review – support robust, regulator‑ready deliverables.

Upcoming webinars

All webinars

Model-Informed Drug Discovery and Development (MID3): Transforming strategic decision making in oncology

January 21, 2026  |  10:00–11:00 (EST)